Back

Meta-analysis comparing sirolimus bioresorbable scaffolds versus everolimus-eluting metallic stents in coronary arterial disease

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters Revascularisation ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Rohan Prasad

Michigan State University, East Lansing (United States of America)

178 More presentations in this session

Presentation thumbnail
The quest for GRACE 3.0: improving our beloved risk score with machine learning
Doctor J. Sousa (Porto, PT)
Abstract Slides
Presentation thumbnail
Percutaneous coronary interventions in patients with left main coronary artery pseudobifurcation lesions: 5-years follow-up
Associate Professor D. Maximkin (Moscow, RU)
Abstract Slides
Presentation thumbnail
Use of intima media thickness in the assessment of the development of preclinical atherosclerosis
Associate Professor R. Najafov (Baku, AZ)
Abstract Slides
Presentation thumbnail
Long term outcomes of patients with chronic inflammatory diseases after percutaneous coronary intervention
Doctor O. Kobo (Hadera, IL)
Abstract Slides
Presentation thumbnail
Feasibility, safety and long term outcomes of complex left main bifurcation treatment using the nano inverted t stenting: a multicentre registry
Associate Professor G. Rigatelli (Rovigo, IT)
Abstract Slides

Access the full session

Session thumbnail
Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources